Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer

Strahlentherapie und Onkologie

Volumn 185, Issue 11, 2009, Pages 731-735

  Ghadjar, Pirus ^a   Gwerder, Nicole ^a   Madlung, Axel ^a   Behrensmeier, Frank ^a   Thalmann, George N ^a   Mini, Roberto ^a   Aebersold, Daniel M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Gold markers; HDR B; IGRT; Monotherapy; Prostate cancer

Indexed keywords

GOLD; MARKER;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; HUMAN; MALE; PROSTATE ADENOCARCINOMA; RADIATION APPLICATOR; RADIATION DOSE FRACTIONATION; RADIOGRAPHY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DOSE FRACTIONATION; FOLLOW-UP STUDIES; GOLD; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; UROGENITAL SYSTEM;

EID: 70449767181     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-009-2007-7     Document Type: Article

References (27)

1. D.M. Aebersold B. Isaak G. Thalmann, et al. 2004 Applicability and dosimetric impact of ultrasound-based preplanning in high-dose-rate brachytherapy of prostate cancer Strahlenther Onkol 180 351 357 10.1007/s00066-004-1225-2 15175869 (Pubitemid 38720330)
2. S. Bracarda O. de Cobelli C. Greco, et al. 2005 Cancer of the prostate Crit Rev Oncol Hematol 56 379 396 10.1016/j.critrevonc.2005.03.010 16310371 (Pubitemid 41677619)
3. D.J. Brenner E.J. Hall 1999 Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1095 1101 10.1016/S0360-3016(98)00438-6 1:STN:280:DyaK1M3gs1Gkuw%3D%3D 10192361 (Pubitemid 29144800)
4. C. Corner A.M. Rojas L. Bryant, et al. 2008 A phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer Int J Radiat Oncol Biol Phys 72 441 446 18249501
5. D.J. Demanes R.R. Rodriguez L. Schour, et al. 2005 High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10 year results Int J Radiat Oncol Biol Phys 61 1306 1316 15817332
6. W. Dörr J. Jaal D. Zips 2007 Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy Strahlenther Onkol 183 14 15 10.1007/s00066-007-2006-5 18166999
7. S.M. Eulau L. Van Hollebeke W. Cavanagh, et al. 2000 High dose rate iridium 192 brachytherapy in localized prostate cancer: results and toxicity with maximum follow-up of 10 years Int J Radiat Oncol Biol Phys 48 Suppl 149
8. J.F. Fowler 1989 The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 679 694 10.1259/0007-1285-62-740-679 1:STN:280:DyaL1Mzltlantg%3D%3D 2670032
9. R.M. Galalae A. Martinez T. Mate, et al. 2004 Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen supression for localized prostate cancer Int J Radiat Oncol Biol Phys 58 1048 1055 15001244
10. P. Ghadjar T. Keller C.A. Rentsch, et al. 2009 Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy Brachytherapy 8 45 51 10.1016/j.brachy.2008.09.004 19038584
11. I.S. Grills A.A. Martinez M. Hollander, et al. 2004 High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds J Urol 171 1098 1104 10.1097/01.ju.0000113299.34404.22 14767279 (Pubitemid 38327535)
12. M. Guckenberger M. Flentje 2007 Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives Strahlenther Onkol 183 57 62 10.1007/s00066-007-1631-3 17294108 (Pubitemid 46255023)
13. J. Hiratsuka Y. Jo K. Yoshida, et al. 2004 Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer Int J Radiat Oncol Biol Phys 59 684 690 15183471
14. P.J. Hoskin P.J. Brownes P. Ostler, et al. 2003 High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions Radiother Oncol 68 285 288 10.1016/S0167-8140(03)00203-2 13129636 (Pubitemid 38373429)
15. A. Jemal R. Siegel E. Ward, et al. 2006 Cancer statistics, 2006 CA Cancer J Clin 56 106 130 10.3322/canjclin.56.2.106 16514137
16. T. Martin D. Baltas R. Kurek, et al. 2004 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study Strahlenther Onkol 180 225 232 10.1007/s00066-004-1215-4 15057433 (Pubitemid 38461547)
17. A.A. Martinez G. Gustafson J. Gonzalez, et al. 2002 Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer Int J Radiat Oncol Biol Phys 53 316 327 12023135
18. A.A. Martinez I. Pataki G. Edmundson, et al. 2001 Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report Int J Radiat Oncol Biol Phys 49 61 69 1:STN:280:DC%2BD3M7nslCktg%3D%3D 11163498
19. A.C. Pellizzon W. Nadalin J.V. Salvajoli, et al. 2003 Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer Radiother Oncol 66 167 172 10.1016/S0167-8140(02)00408-5 12648788 (Pubitemid 36315826)
20. M. Pinkawa B. Gagel M.D. Piroth, et al. 2006 Changes of dose delivery distribution within the first month after permanent interstitial brachytherapy for prostate cancer Strahlenther Onkol 182 525 530 10.1007/s00066-006-1529-5 16944374 (Pubitemid 44316241)
21. D. Rades R. Schwarz M. Todorovic, et al. 2007 Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer Strahlenther Onkol 183 398 402 10.1007/s00066-007-1643-z 17609874 (Pubitemid 47036699)
22. M. Roach 3rd 2007 Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both? Strahlenther Onkol 183 26 28 10.1007/s00066-007-2011-8 18167004
23. M. Roach 3rd G. Hanks H. Thames Jr, et al. 2006 Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference Int J Radiat Oncol Biol Phys 65 965 974 16798415
24. Sobin LH, Wittekind CH. The prostate. In: Sobin LH, Wittekind CH, eds. TNM classification of malignant tumors. New York: Wiley-Liss, 2002:184-187.
25. Y. Yoshioka K. Konishi R.J. Oh, et al. 2006 High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer Radiother Oncol 80 62 68 10.1016/j.radonc.2006.06.011 16870289 (Pubitemid 44226435)
26. Y. Yoshioka T. Nose K. Yoshida, et al. 2000 High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial Int J Radiat Oncol Biol Phys 48 675 681 1:STN:280:DC%2BD3M%2FgvFagtw%3D%3D 11020563
27. Y. Yoshioka T. Nose K. Yoshida, et al. 2003 High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity Int J Radiat Oncol Biol Phys 56 213 220 12694841